AIM is trading at $0.29 (5.8% down) following a series of recent dilutive financings that have increased share supply and pressured the stock.

  • The company announced a $2.65 million registered direct offering and private placement in June.
  • A subsequent rights offering raised approximately $1.8 million, further impacting the share price as broader market indices trade modestly lower.